CI
EW icon

CX Institutional’s Edwards Lifesciences EW Stock Holding History

CX Institutional’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$533K Buy
5,897
+631
+12% +$52.9K 0.02% 463
2026
Q1 		$422K Buy
5,266
+728
+16% +$60K 0.01% 507
2025
Q4 		$387K Buy
4,538
+218
+5% +$17.9K 0.01% 497
2025
Q3 		$336K Buy
4,320
+6
+0.1% +$469 0.01% 535
2025
Q2 		$337K Buy
4,314
+416
+11% +$31K 0.01% 470
2025
Q1 		$283K Sell
3,898
-70
-2% -$5.01K 0.01% 496
2024
Q4 		$294K Buy
+3,968
New +$278K 0.01% 450
2024
Q3 		– Sell
-3,775
Closed -$349K – 562
2024
Q2 		$349K Sell
3,775
-38
-1% -$3.37K 0.02% 425
2024
Q1 		$364K Buy
3,813
+1,240
+48% +$104K 0.02% 417
2023
Q4 		$196K Sell
2,573
-1,059
-29% -$73.7K 0.01% 492
2023
Q3 		$252K Sell
3,632
-885
-20% -$71.1K 0.01% 437
2023
Q2 		$426K Buy
4,517
+131
+3% +$11.4K 0.02% 365
2023
Q1 		$361K Buy
4,386
+434
+11% +$34.1K 0.02% 386
2022
Q4 		$295K Buy
+3,952
New +$305K 0.02% 431
2022
Q3 		– Sell
-1,212
Closed -$115K – 683
2022
Q2 		$115K Buy
+1,212
New +$125K 0.01% 532
2021
Q4 		– Sell
-1,243
Closed -$141K – 519
2021
Q3 		$141K Buy
1,243
+89
+8% +$10.2K 0.01% 396
2021
Q2 		$120K Buy
1,154
+409
+55% +$38.6K 0.01% 409
2021
Q1 		$62K Sell
745
-57
-7% -$4.82K 0.01% 451
2020
Q4 		$73K Buy
802
+269
+50% +$22.3K 0.01% 396
2020
Q3 		$43K Buy
533
+211
+66% +$16.5K ﹤0.01% 409
2020
Q2 		$22K Buy
322
+82
+34% +$5.83K ﹤0.01% 420
2020
Q1 		$15K Buy
240
+90
+60% +$6.49K ﹤0.01% 411
2019
Q4 		$12K Hold
150
– – ﹤0.01% 408
2019
Q3 		$11K Buy
150
+12
+9% +$843 ﹤0.01% 449
2019
Q2 		$8K Hold
138
– – ﹤0.01% 523
2019
Q1 		$9K Buy
138
+111
+411% +$6.33K ﹤0.01% 470
2018
Q4 		$1K Buy
+27
New +$1.37K ﹤0.01% 491

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return

CX Institutional's EW Position: Q2 2026 in Review

CX Institutional increased its Edwards Lifesciences (EW) stake by 12% in Q2 2026, buying an estimated $52.9K and bringing the position to 5,897 shares worth $533K. The position accounts for 0.02% of the portfolio, ranked #463.

CX Institutional first reported a position in EW in Q4 2018 and has held it in 27 quarters since. 269 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • CX Institutional held 5,897 shares of Edwards Lifesciences worth $533K as of Q2 2026.
  • CX Institutional bought 631 Edwards Lifesciences shares in Q2 2026, an estimated $52.9K.
  • Edwards Lifesciences made up 0.02% of CX Institutional's portfolio in Q2 2026, its #463 holding.
  • CX Institutional first reported a position in Edwards Lifesciences in Q4 2018 and has held it in 27 quarters since.
  • 269 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.